This is the authors' abstract. We don't add key points for this paper.
Herein, we synthesized and characterized a binuclear copper(I) complex supported by the indolyl-based ligand. Employing this complex as catalyst, we have developed a three-component intermolecular trifluoromethylazolation of alkenes to deliver various trifluoromethylated azole derivatives. The method features exclusive chemo- and regioselectivity, a broad scope of alkenes and oxazoles, thiazoles, and good tolerance of functional groups under mild conditions. Preliminary mechanistic studies support a radical process for the transformation.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: